• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Yesterday
Sanofi – Consensus Indicates Potential 29.4% Upside DirectorsTalk Interviews12:34 10-Apr-21
In the last 7 days
Sanofi completes Kymab acquisition Sanofi (Press Release)06:14 9-Apr-21
Sanofi Inks Agreement to Build Influenza Vaccine Manufacturing Facility in Canada Genetic Engineering and Biotechnology News15:16 5-Apr-21
In the last month
Sanofi invests in influenza vaccine facility in Canada Manufacturing Chemist14:20 1-Apr-21
N.D. Alabama Delivers One-Two Punch – Part Two Drug & Device Law09:18 23-Mar-21
Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy Genetic Engineering and Biotechnology News18:08 21-Mar-21
Sanofi – Consensus Indicates Potential 30.9% Upside DirectorsTalk Interviews21:22 18-Mar-21
Coronavirus: The Moth Vaccine Science Museum Group09:05 18-Mar-21
GBT Bucks Gene Therapy Trend With Sanofi Sickle Cell Deal Scrip Pharma Intelligence16:26 17-Mar-21
view more headlines
10 Apr 13:34

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.